Association between heat and hospital admissions in people with disabilities in South Korea: a nationwide, case-crossover study

The Lancet Planetary Health, Год журнала: 2024, Номер 8(4), С. e217 - e224

Опубликована: Апрель 1, 2024

BackgroundDespite extensive findings on the hazardous impacts of environmental heat exposure, little is known about effect people with disabilities. This study aimed to estimate association between exposure and emergency department admissions for disabilities compared without disabilities.MethodsIn this nationwide, case-crossover study, we linked data (cases) any cause in warm season South Korea from Korean National Health Insurance Service (NHIS)–National Sample Cohort database (a nationally representative 1 million systematically sampled beneficiaries covering all ages) Jan 1, 2002, Dec 31, 2019, short-term daily mean temperature (measured via Google Earth Engine at a 9 km spatial grid, aggregated district). We defined as those who were registered disabled NHIS; included our physical disability, brain lesion disorders, blindness or vision loss, deafness hearing loss. Other types disability not confidentiality reasons. A time-stratified design, which participants served their own control, was used conditional logistic regression disabilities.Findings23 792 recorded 59 527 Of these 23 admissions, 10 234 (43·0%) individuals female 13 558 (57·0%) male. The odds ratio (OR) associated (99th percentile vs 75th percentile) 1·15 (95% CI 1·07–1·24) 1·06 (1·04–1·09) annual excess number attributable per 100 000 persons-years 27·81 9·20–45·69) medical costs US$638 739·47 201 900·12–1 059 641·87) disabilities; values more than four times that non-disabled population. People severe disabilities, individuals, aged 65 years older showed higher risks. risks due mental disorder (1·89, 95% 1·18–3·00) respiratory diseases (1·34, 1·06–1·70) also other two analysed causes admission (cardiovascular genitourinary diseases).InterpretationHeat increased risk but appeared be These results can inform policy makers when establishing action plans disabilities.FundingNational Research Foundation Korea, Ministry Environment, Education.

Язык: Английский

---

Factors Associated with the Use of Psychotropic Medication in a Norwegian Community-Based Sample of Adults with Intellectual Disability

Journal of Mental Health Research in Intellectual Disabilities, Год журнала: 2025, Номер unknown, С. 1 - 23

Опубликована: Янв. 13, 2025

Язык: Английский

---

Less antipsychotics, more Quality of Life tapering strategies for adults with intellectual disabilities and challenging behaviour

Research in Developmental Disabilities, Год журнала: 2025, Номер 162, С. 105020 - 105020

Опубликована: Апрель 22, 2025

Язык: Английский

---

Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors

Journal of Applied Research in Intellectual Disabilities, Год журнала: 2022, Номер 35(5), С. 1109 - 1118

Опубликована: Апрель 5, 2022

Abstract Background Psychotropic medication is frequently administered to people with intellectual disability mental health and/or behavioural problems, instead of other non‐pharmacological interventions. This study describes the and problems aging disability, their psychotropic intake, factors contributing a greater intake. Method The sample consisted 991 over 45 years. Descriptive statistics multinominal logistic regression were carried out. Results Antipsychotics most used drug. Older mild living in institutions affected by more likely take larger amounts medication. Conclusions continue be widely especially those institutionalised settings. Future research should consider if intake could reduced providing better supports community

Язык: Английский

---

Co-Occurring Mental Illness and Behavioral Support Needs in Adults with Intellectual and Developmental Disabilities

Community Mental Health Journal, Год журнала: 2023, Номер 59(6), С. 1119 - 1128

Опубликована: Фев. 5, 2023

Язык: Английский

---

A survey on service users' perspectives about information and shared decision‐making in psychotropic drug prescriptions in people with intellectual disabilities

British Journal of Learning Disabilities, Год журнала: 2024, Номер 52(2), С. 350 - 361

Опубликована: Фев. 1, 2024

Abstract Background In people with intellectual disabilities and mental disorders and/or challenging behaviours, rates of psychotropic drug prescription are high. clinical treatments evaluations, all stakeholders should be involved in a process shared decision‐making (SDM). We aimed to investigate the perspectives clients their carers on clients’ drugs. Methods conducted survey among adults Dutch healthcare centre providing community, outpatient inpatient care. Data were collected between January June 2022. Questions focused experiences provision information, treatment involvement SDM participants' wishes this regard. Findings Respondents (57 21 carers) largely satisfied overall care from clinicians, how information pharmacological was provided verbally, but written insufficient or not provided. Seventy per cent 60% reported being medication decision‐making. However, over 75% participants desired greater reviews. Conclusions Service users representatives about verbal use. The ongoing evaluation use could improved.

Язык: Английский

---

Restrictive Practice Use in People with Neurodevelopmental Disorders: A Systematic Review

Advances in Neurodevelopmental Disorders, Год журнала: 2023, Номер 8(1), С. 122 - 140

Опубликована: Окт. 19, 2023

Язык: Английский

---

Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Prescribers

International Journal of Environmental Research and Public Health, Год журнала: 2022, Номер 19(24), С. 17095 - 17095

Опубликована: Дек. 19, 2022

International current best practice recommends the discontinuation of antipsychotics for challenging behaviours in people with intellectual disabilities (ID), due to lack evidence efficacy and risks harmful side-effects. In clinical practice, may be difficult. The aim this study was gain insight into prescribers’ by investigating their experiences long-term behaviour. From professionals’ associations thirty-four registered ID physicians, psychiatrists specialist mental healthcare nurses were recruited who completed an online questionnaire survey–study. Almost all participants had attempted deprescribe patients ID. Sixty-five percent achieved complete 0–25% patients, but none over 50%. Barriers a non-pharmaceutical treatments caregivers’ and/or family concern. Seventy indicated that institutions encouraged implementing policies line new Dutch Act on Involuntary care multidisciplinary guideline problem behaviour adults Support facilitation clinicians from institutions’ managers political professional bodies helpful further implementation treatment

Язык: Английский

---

OPTIMA-ID: development and validation of a medicine optimization tool for older adults with intellectual disability

Expert Review of Clinical Pharmacology, Год журнала: 2024, Номер 17(9), С. 837 - 851

Опубликована: Авг. 13, 2024

Background Older people (i.e. ≥40 years) with intellectual disability have unique medication needs and may experience high levels of potentially inappropriate prescribing. Despite the availability tools to optimize older adults' prescriptions, there is no comprehensive tool specifically for use in adults disability. We aimed develop a this purpose: Optimizing Pharmaco-Therapy Improving Medication Ageing Intellectual Disability (OPTIMA-ID).

Язык: Английский

---

Antipsychotic medication in people with intellectual disability and schizophrenia: A 25-year updated systematic review and cross-sectional study

Journal of Psychopharmacology, Год журнала: 2024, Номер unknown

Опубликована: Сен. 12, 2024

To determine the efficacy and safety of antipsychotic medication for treating individuals with a dual diagnosis intellectual disability (ID) schizophrenia.

Язык: Английский

---